| Product Code: ETC9966894 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Genomics Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Genomics Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Genomics Market - Industry Life Cycle |
3.4 United States (US) Genomics Market - Porter's Five Forces |
3.5 United States (US) Genomics Market Revenues & Volume Share, By Application & Technology, 2021 & 2031F |
3.6 United States (US) Genomics Market Revenues & Volume Share, By Technology Outlook, 2021 & 2031F |
3.7 United States (US) Genomics Market Revenues & Volume Share, By Deliverables, 2021 & 2031F |
3.8 United States (US) Genomics Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 United States (US) Genomics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision healthcare |
4.2.2 Technological advancements in genomics, such as CRISPR gene-editing technology |
4.2.3 Growing investments in genomics research and development |
4.3 Market Restraints |
4.3.1 High cost of genomic testing and sequencing services |
4.3.2 Data privacy and security concerns related to genomic data |
4.3.3 Regulatory challenges and compliance requirements in the genomics industry |
5 United States (US) Genomics Market Trends |
6 United States (US) Genomics Market, By Types |
6.1 United States (US) Genomics Market, By Application & Technology |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Genomics Market Revenues & Volume, By Application & Technology, 2021- 2031F |
6.1.3 United States (US) Genomics Market Revenues & Volume, By Functional Genomics, 2021- 2031F |
6.1.4 United States (US) Genomics Market Revenues & Volume, By Epigenomics, 2021- 2031F |
6.1.5 United States (US) Genomics Market Revenues & Volume, By Pathway Analysis, 2021- 2031F |
6.1.6 United States (US) Genomics Market Revenues & Volume, By Biomarker Discovery, 2021- 2031F |
6.1.7 United States (US) Genomics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Genomics Market, By Technology Outlook |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Genomics Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.2.3 United States (US) Genomics Market Revenues & Volume, By PCR, 2021- 2031F |
6.2.4 United States (US) Genomics Market Revenues & Volume, By Flow Cytometry, 2021- 2031F |
6.2.5 United States (US) Genomics Market Revenues & Volume, By Microarrays, 2021- 2031F |
6.2.6 United States (US) Genomics Market Revenues & Volume, By Other technologies, 2021- 2031F |
6.3 United States (US) Genomics Market, By Deliverables |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Genomics Market Revenues & Volume, By Products, 2021- 2031F |
6.3.3 United States (US) Genomics Market Revenues & Volume, By Services, 2021- 2031F |
6.4 United States (US) Genomics Market, By End-use |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Genomics Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.4.3 United States (US) Genomics Market Revenues & Volume, By Academic & Government Institutes, 2021- 2031F |
6.4.4 United States (US) Genomics Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.4.5 United States (US) Genomics Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.6 United States (US) Genomics Market Revenues & Volume, By Other End Users, 2021- 2031F |
7 United States (US) Genomics Market Import-Export Trade Statistics |
7.1 United States (US) Genomics Market Export to Major Countries |
7.2 United States (US) Genomics Market Imports from Major Countries |
8 United States (US) Genomics Market Key Performance Indicators |
8.1 Percentage increase in research funding allocated to genomics projects |
8.2 Number of new partnerships and collaborations in the genomics sector |
8.3 Growth in the number of genomic data repositories and databases |
8.4 Adoption rate of genomic testing and sequencing technologies |
8.5 Rate of advancements in genomic data analysis tools and software |
9 United States (US) Genomics Market - Opportunity Assessment |
9.1 United States (US) Genomics Market Opportunity Assessment, By Application & Technology, 2021 & 2031F |
9.2 United States (US) Genomics Market Opportunity Assessment, By Technology Outlook, 2021 & 2031F |
9.3 United States (US) Genomics Market Opportunity Assessment, By Deliverables, 2021 & 2031F |
9.4 United States (US) Genomics Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 United States (US) Genomics Market - Competitive Landscape |
10.1 United States (US) Genomics Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Genomics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here